Quanterix, Biomérieux Ink Licensing Deal
Quanterix announced on Monday it and BioMérieux have signed a new licensing deal giving both firms greater flexibility to commercialize products within their respective fields.
As part of the new agreement, Quanterix will have broader licensing rights within the in vitro diagnostic field, and it and BioMérieux will have the ability to develop instruments for commercialization within the IVD space, Quanterix said.
Read the rest of the article at 360dx.com
Share this page